Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
Howard A. Burris
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
Guangyi Zhao et al.
PLOS ONE (2013)
The MAPK Pathway Signals Telomerase Modulation in Response to Isothiocyanate-Induced DNA Damage of Human Liver Cancer Cells
Evelyn Lamy et al.
PLOS ONE (2013)
APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway
Guihua Wang et al.
PLOS ONE (2013)
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
M. R. Milone et al.
CELL DEATH & DISEASE (2013)
Alzheimer Disease Susceptibility Loci: Evidence for a Protein Network under Natural Selection
Towfique Raj et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Raf kinase inhibitor protein (RKIP) in cancer
June Escara-Wilke et al.
CANCER AND METASTASIS REVIEWS (2012)
Targeting the EGFR signaling pathway in cancer therapy
Parthasarathy Seshacharyulu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Identification of frequent BRAF copy number gain and alterations of RAF genes in chinese prostate cancer
Guoping Ren et al.
GENES CHROMOSOMES & CANCER (2012)
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4
Jianfeng Xu et al.
NATURE GENETICS (2012)
TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer
M-C Shih et al.
ONCOGENE (2012)
The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer
Hae-Yun Jung et al.
CANCER RESEARCH AND TREATMENT (2012)
ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells
Byung-Kwon Choi et al.
CANCER MEDICINE (2012)
Shared and Unique Components of Human Population Structure and Genome-Wide Signals of Positive Selection in South Asia
Mait Metspalu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer
Louise R. Howe et al.
CANCER PREVENTION RESEARCH (2011)
Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3
Liqun Chen et al.
CLINICAL CANCER RESEARCH (2011)
Key pathways involved in prostate cancer based on gene set enrichment analysis and meta analysis
Q. Y. Ning et al.
GENETICS AND MOLECULAR RESEARCH (2011)
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2011)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans
Victor Acuna-Alonzo et al.
HUMAN MOLECULAR GENETICS (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
A Two-stage Case-Control Study of EGFR Polymorphisms and Breast Cancer Risk
Young-Seoub Hong et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Androgen Receptor Controls EGFR and ERBB2 Gene Expression at Different Levels in Prostate Cancer Cell Lines
Jean-Christophe Pignon et al.
CANCER RESEARCH (2009)
Pathway Analysis by Adaptive Combination of P-Values
Kai Yu et al.
GENETIC EPIDEMIOLOGY (2009)
Targeted resequencing of two genes, RAGE and POLL, confirms findings from a genome-wide scan for adaptive evolution and provides evidence for positive selection in additional populations
Joanna L. Kelley et al.
HUMAN MOLECULAR GENETICS (2009)
An Analysis of Growth, Differentiation and Apoptosis Genes with Risk of Renal Cancer
Linda M. Dong et al.
PLOS ONE (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Integrating signals from RTKs to ERK/MAPK
M. M. McKay et al.
ONCOGENE (2007)
R115777 (Zarnestra®)/Zoledronic acid (Zometa®) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation
Michele Caraglia et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
A map of recent positive selection in the human genome (vol 4, pg 154, 2006)
BF Voight et al.
PLOS BIOLOGY (2006)
A map of recent positive selection in the human genome
BF Voight et al.
PLOS BIOLOGY (2006)
Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway
RJ Orton et al.
BIOCHEMICAL JOURNAL (2005)
Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF
V Emuss et al.
CANCER RESEARCH (2005)
A haplotype map of the human genome
D Altshuler et al.
NATURE (2005)
Selection strength and hitchhiking around two anti-malarial resistance genes
D Nash et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2005)
Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility
J Lacoste et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Modulation of signalling by sprouty: A developing story
HJ Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Rank truncated product of P-values, with application to genomewide association scans
F Dudbridge et al.
GENETIC EPIDEMIOLOGY (2003)
Detecting recent positive selection in the human genome from haplotype structure
PC Sabeti et al.
NATURE (2002)
HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer
CL Arteaga et al.
SEMINARS IN ONCOLOGY (2002)
Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling
M Sumitomo et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
